您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > P8RI
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
P8RI
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
P8RI图片
规格:98%
分子量:1016.24
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
P8RI (D-P8RI) 是CD31的模拟肽和 CD31 激动剂。P8RI 与 CD31 外结构域的膜旁氨基酸序列结合,通过恢复 CD31 抑制途径显示出免疫抑制作用。
货号:ajcx35758
CAS:2147724-76-1
分子式:C51H77N13O9
分子量:1016.24
溶解度:H2O : 100 mg/mL (98.40 mM; Need ultrasonic)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. P8RI binds to the juxtamembrane amino acid sequence of the ectodomain of CD31, shows an immunosuppressive effect through restoration of the CD31 inhibitory pathway[1][2].

P8RI (D-P8RI) was designed as a retro-inverso peptide with all-D-amino acids allowing to maintain bioactivity and to confer resistance towards plasma proteases[1].

P8RI (2.5 mg/kg; s.c.; daily from 7 to 28 after the occurrence of ADIM) prevents aneurysmal transformation by promoting the resolution of intramural hematoma and the production of collagen in dissected aortas in vivo, associated with enrichment of M2 macrophages at the site of injury[3].

[1]. Diaz-Rodriguez S, et al. Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo. Eur Heart J. 2021;42(18):1760-1769. [2]. Sannier A, et al. A CD31-Derived Peptide Prevents the Development of Antibody-Mediated Lesions in a Rat Model of Aortic Allograft. Transplant Proc. 2021;53(2):746-749. [3]. Andreata F, et al. Macrophage CD31 Signaling in Dissecting Aortic Aneurysm. J Am Coll Cardiol. 2018;72(1):45-57.